Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach
- PMID: 8085280
- DOI: 10.1097/00007691-199406000-00006
Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach
Abstract
A population analysis of the kinetics of lithium was performed from experimental and observational data in 113 subjects in order to propose a new approach for lithium dosage individualization. The kinetics of lithium is described by a two-compartment model. Age, body weight, height, and serum creatinine are included as covariates. Population analysis was performed by the nonparametric maximum likelihood method, which provides an estimate of the distribution of the five kinetic parameters and covariates. Mean lithium clearance was 1.50 L/h with a coefficient of variation (CV) of 38%, and was found to increase with body weight. Results were consistent with those of earlier studies and confirm a large interindividual variability. Data from a separate group of 35 patients were used to validate results: the estimated a priori and on covariate conditional distributions of the measured 24-h serum lithium concentration following a single dose were consistent with the corresponding measurements. A Bayesian approach for individualizing dosing schemes is proposed. This approach is based on minimization of a risk function expressing the deviation of the trough concentration at steady-state from the therapeutic range.
Similar articles
-
Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.Ther Drug Monit. 1993 Apr;15(2):75-82. doi: 10.1097/00007691-199304000-00002. Ther Drug Monit. 1993. PMID: 8503142
-
A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters.J Pharmacokinet Biopharm. 1979 Dec;7(6):579-628. doi: 10.1007/BF01061210. J Pharmacokinet Biopharm. 1979. PMID: 529025
-
Estimation of lithium clearance in patients with bipolar disorder.Int Clin Psychopharmacol. 2020 May;35(3):157-162. doi: 10.1097/YIC.0000000000000301. Int Clin Psychopharmacol. 2020. PMID: 31851034
-
A review of lithium dosing methods.Pharmacotherapy. 1988;8(4):248-55. doi: 10.1002/j.1875-9114.1988.tb04080.x. Pharmacotherapy. 1988. PMID: 3057477 Review.
-
Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?Clin Pharmacokinet. 2002;41(9):639-60. doi: 10.2165/00003088-200241090-00002. Clin Pharmacokinet. 2002. PMID: 12126457 Review.
Cited by
-
Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder.Eur J Clin Pharmacol. 2019 Apr;75(4):519-528. doi: 10.1007/s00228-018-2605-3. Epub 2018 Dec 15. Eur J Clin Pharmacol. 2019. PMID: 30554270
-
Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates.Clin Pharmacokinet. 2007;46(1):59-74. doi: 10.2165/00003088-200746010-00003. Clin Pharmacokinet. 2007. PMID: 17201458
-
Accuracy of the Pepin method to determine appropriate lithium dosages in healthy volunteers.J Psychiatry Neurosci. 2001 Sep;26(4):330-5. J Psychiatry Neurosci. 2001. PMID: 11590973 Free PMC article.
-
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003. Clin Pharmacokinet. 2006. PMID: 16584284
-
Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.Clin Pharmacokinet. 1998 Jan;34(1):57-77. doi: 10.2165/00003088-199834010-00003. Clin Pharmacokinet. 1998. PMID: 9474473 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources